Comparison of gait in progressive supranuclear palsy, Parkinson's disease and healthy older adults

被引:35
|
作者
Egerton, Thorlene [1 ,3 ]
Williams, David R. [4 ]
Iansek, Robert [1 ,2 ,3 ]
机构
[1] Natl Parkinson Fdn Ctr Excellence, Clin Res Ctr Movement Disorders & Gait, Cheltenham, Vic, Australia
[2] Kingston Ctr, Clin Res Ctr Movement Disorders & Gait, Cheltenham, Vic 3192, Australia
[3] Kingston Ctr, Victorian Comprehens Parkinsons Program, Cheltenham, Vic, Australia
[4] Monash Univ, Van Cleef Roet Ctr Nervous Dis, Clayton, Vic, Australia
来源
BMC NEUROLOGY | 2012年 / 12卷
关键词
Progressive supranuclear palsy; Parkinson's disease; Gait; Older people; GAITRITE(R) WALKWAY SYSTEM; STRIDE LENGTH; VARIABILITY; PARAMETERS; PEOPLE; QUANTIFICATION; DEGENERATION;
D O I
10.1186/1471-2377-12-116
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Progressive supranuclear palsy and Parkinson's disease have characteristic clinical and neuropathologic profiles, but also share overlapping clinical features. This study aimed to analyze the gait of people with progressive supranuclear palsy (n=19) and compare it with people with Parkinson's disease (n=20) and healthy older adults (n=20). Methods: Gait was recorded at self-selected preferred, fast, very fast, slow and very slow speeds. Stride length was normalized to leg length. Linear regression analyses were carried out between cadence and stride length. Other gait variables were compared for each participant's 'walk' which had stride length closest to 1.4. Results: All groups showed a strong linear relationship between stride length and cadence with no difference between groups (p>0.05). The intercept between cadence and stride length was lowest in the progressive supranuclear palsy group and highest for older adults (p<0.001). The progressive supranuclear palsy group had higher cadence than older adults (p>0.05), and greater step width and greater double support phase compared with the other two groups (p<0.05). Conclusions: The temporal-spatial gait characteristics of progressive supranuclear palsy and Parkinson's disease are largely similar, with similar disruption to scaling of stride length. The additional findings of increased step width and double support percentage suggest increased severity of gait abnormality compared to Parkinson's disease, despite similar disease duration. The findings are consistent with the clinical features of greater instability and more rapid disease progression in progressive supranuclear palsy compared to Parkinson's disease and implicates the early pathological involvement of brain regions involved in gait control.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease
    Halliday, GM
    Macdonald, V
    Henderson, JM
    [J]. BRAIN, 2005, 128 : 2272 - 2280
  • [22] Visual fixation suppression of caloric nystagmus in progressive supranuclear palsy - A comparison with Parkinson's disease
    Naito, Rie
    Watanabe, Yuki
    Naito, Akira
    Sugasawa, Keiko
    Nakata, Yasuhiro
    Kamiyama, Tsutomu
    Okiyama, Ryoichi
    Yokochi, Fusako
    Isozaki, Eiji
    Yamasoba, Tatsuya
    Takahashi, Kazushi
    [J]. JOURNAL OF VESTIBULAR RESEARCH-EQUILIBRIUM & ORIENTATION, 2023, 33 (06): : 385 - 401
  • [23] Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson's disease and multiple system atrophy
    Kim, Kyeong Joon
    Jeong, Seong Jin
    Kim, Jong-Min
    [J]. NEUROUROLOGY AND URODYNAMICS, 2018, 37 (05) : 1724 - 1730
  • [24] Colonic transit time in progressive supranuclear palsy and Parkinson's disease
    Sakakibara, Ryuji
    Doi, Hirokazu
    Tateno, Fuyuki
    Aiba, Yosuke
    Sawai, Setsu
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 338 - 338
  • [25] Tau intronic polymorphism in Parkinson's disease and progressive supranuclear palsy
    Lazzarini, AM
    Golbe, LI
    Dickson, DW
    Duvoisin, RC
    Johnson, WG
    [J]. NEUROLOGY, 1997, 48 (03) : 6088 - 6088
  • [26] Comparison of motor cortex excitability in progressive supranuclear palsy, Parkinson's disease and healthy controls: a transcranial magnetic stimulation study
    Fichera, M.
    Houdayer, E.
    Avantaggiato, F.
    Chieffo, R.
    Comi, G.
    Volonte, M. A.
    Leocani, L.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 41 - 41
  • [27] Sensitivity and Specificity of the ECAS in Parkinson's Disease and Progressive Supranuclear Palsy
    Foley, Jennifer A.
    Niven, Elaine H.
    Paget, Andrew
    Bhatia, Kailash P.
    Farmer, Simon F.
    Jarman, Paul R.
    Limousin, Patricia
    Warner, Thomas T.
    Morris, Huw R.
    Bak, Thomas H.
    Abrahams, Sharon
    Cipolotti, Lisa
    [J]. PARKINSONS DISEASE, 2018, 2018
  • [28] Co-occurrence of Parkinson's disease with progressive supranuclear palsy
    Judkins, AR
    Forman, MS
    Uryu, K
    Hinkle, DA
    Asbury, AK
    Lee, VMY
    Trojanowski, JQ
    [J]. ACTA NEUROPATHOLOGICA, 2002, 103 (05) : 526 - 530
  • [29] OCULOMOTOR ABNORMALITIES IN PATIENTS WITH PARKINSON'S DISEASE AND PROGRESSIVE SUPRANUCLEAR PALSY
    Kocoglu, K.
    Boz, H. Eraslan
    Akkoyun, M.
    Colakoglu, B. Donmez
    Cakmur, R.
    Akdal, G.
    [J]. PARKINSONISM & RELATED DISORDERS, 2020, 79 : E40 - E40
  • [30] Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease
    Aarsland, D
    Litvan, I
    Larsen, JP
    [J]. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2001, 13 (01) : 42 - 49